Atlas Trials

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

Clinical trial NCT03988842 · TERMINATED

Trial details

NCT number
NCT03988842
Sponsor
Victor Tapson, MD
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Embolism With Acute Cor PulmonalePulmonary EmbolismPulmonary Embolism With Pulmonary InfarctionPulmonary Embolism Subacute MassiveRight Ventricular DysfunctionRight Ventricular Failure
Start date
2019-07-25
Primary completion
2020-04-05
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.